| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
|
|
|
||||||||||
|
||||||||||||
The British Journal of Psychiatry 148: 120-127 (1986)
© 1986 The Royal College of Psychiatrists
TJ Crow, JF MacMillan, AL Johnson and EC Johnstone
Out of 253 patients fulfilling criteria for a first episode of schizophrenic illness, 120 entered a randomised placebo-controlled trial of maintenance neuroleptic medication on discharge; they were followed to relapse or loss to follow-up, for two years or to the end of the study. Of those on active medication, 46% relapsed, as did 62% of those on placebo; the most important determinant of relapse was duration of illness prior to starting neuroleptic medication. This finding might be because extended duration of symptoms before admission is more likely to be present in illnesses which in any case will have poor prognosis, or because susceptibility to relapse is reduced by early institution of treatment. The study provides no data on which a decision between these alternative explanations can be based.
This article has been cited by other articles:
|
|
 |
|
  T. R. E. Barnes, V. C. Leeson, S. H. Mutsatsa, H. C. Watt, S. B. Hutton, and E. M. Joyce Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia The British Journal of Psychiatry, September 1, 2008; 193(3): 203 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Kane and S. Leucht Unanswered Questions in Schizophrenia Clinical Trials Schizophr Bull, March 1, 2008; 34(2): 302 - 309. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Kane New-Onset Schizophrenia: Pharmacologic Treatment Focus, January 1, 2008; 6(2): 167 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Niendam, C. E. Bearden, J. Zinberg, J. K. Johnson, M. O'Brien, and T. D. Cannon The Course of Neurocognition and Social Functioning in Individuals at Ultra High Risk for Psychosis Schizophr Bull, May 1, 2007; 33(3): 772 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Parker and S. Lewis Identification of young people at risk of psychosis Advan. Psychiatr. Treat., July 1, 2006; 12(4): 249 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R Bola Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm? Schizophr Bull, April 1, 2006; 32(2): 288 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Perkins, H. Gu, K. Boteva, and J. A. Lieberman Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis Am J Psychiatry, October 1, 2005; 162(10): 1785 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. REMINGTON Rational pharmacotherapy in early psychosis The British Journal of Psychiatry, August 1, 2005; 187(48): s77 - s84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. WARNER Problems with early and very early intervention in psychosis The British Journal of Psychiatry, August 1, 2005; 187(48): s104 - s107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G Robinson, M. G Woerner, H. M Delman, and J. M Kane Pharmacological Treatments for First-Episode Schizophrenia Schizophr Bull, July 1, 2005; 31(3): 705 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.G. C. Owens, P. Miller, S. M. Lawrie, and E. C. Johnstone Pathogenesis of schizophrenia: a psychopathological perspective The British Journal of Psychiatry, May 1, 2005; 186(5): 386 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. Chong, Mythily, A. Lum, Y. H. Chan, and P. McGorry Determinants of Duration of Untreated Psychosis and the Pathway to Care in Singapore International Journal of Social Psychiatry, March 1, 2005; 51(1): 55 - 62. [Abstract] [PDF]
|
|
|
|
|
|
M. Gitlin, K. Nuechterlein, K. L. Subotnik, J. Ventura, J. Mintz, D. L. Fogelson, G. Bartzokis, and M. Aravagiri Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia Focus, January 1, 2004; 2(1): 122 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Lieberman, G. Tollefson, M. Tohen, A. I. Green, R. E. Gur, R. Kahn, J. McEvoy, D. Perkins, T. Sharma, R. Zipursky, et al. Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol Am J Psychiatry, August 1, 2003; 160(8): 1396 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. CARPENTER Jr. Evidence-Based Treatment for First-Episode Schizophrenia? Am J Psychiatry, November 1, 2001; 158(11): 1771 - 1773. [Full Text] [PDF]
|
|
|
|
|
|
M. Gitlin, K. Nuechterlein, K. L. Subotnik, J. Ventura, J. Mintz, D. L. Fogelson, G. Bartzokis, and M. Aravagiri Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia Am J Psychiatry, November 1, 2001; 158(11): 1835 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Spencer, M. Birchwood, and D. McGovern Management of first-episode psychosis Advan. Psychiatr. Treat., March 1, 2001; 7(2): 133 - 140. [Full Text]
|
|
|
|
 |
|
 D. H. Mathalon, E. V. Sullivan, K. O. Lim, and A. Pfefferbaum Progressive Brain Volume Changes and the Clinical Course of Schizophrenia in Men: A Longitudinal Magnetic Resonance Imaging Study Arch Gen Psychiatry, February 1, 2001; 58(2): 148 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T J Crow, D. Curtis, S. Frangou, and P. Byrne How to manage the first episode of schizophrenia BMJ, January 27, 2001; 322(7280): 234a - 234. [Full Text]
|
|
|
|
|
|
R. J. DRAKE, C. J. HALEY, S. AKHTAR, and S. W. LEWIS Causes and consequences of duration of untreated psychosis in schizophrenia The British Journal of Psychiatry, December 1, 2000; 177(6): 511 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Lieberman and W. S. Fenton Delayed Detection of Psychosis: Causes, Consequences, and Effect on Public Health Am J Psychiatry, November 1, 2000; 157(11): 1727 - 1730. [Full Text]
|
|
|
|
|
|
A. L. Hoff, M. Sakuma, K. Razi, G. Heydebrand, J. G. Csernansky, and L. E. DeLisi Lack of Association Between Duration of Untreated Illness and Severity of Cognitive and Structural Brain Deficits at the First Episode of Schizophrenia Am J Psychiatry, November 1, 2000; 157(11): 1824 - 1828. [Abstract] [Full Text]
|
|
|
|
|
|
T. R. E. BARNES, S. B. HUTTON, M. J. CHAPMAN, S. MUTSATSA, B. K. PURI, and E. M. JOYCE West London first-episode study of schizophrenia: Clinical correlates of duration of untreated psychosis The British Journal of Psychiatry, September 1, 2000; 177(3): 207 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-C. Ho, N. C. Andreasen, M. Flaum, P. Nopoulos, and D. Miller Untreated Initial Psychosis: Its Relation to Quality of Life and Symptom Remission in First-Episode Schizophrenia Am J Psychiatry, May 1, 2000; 157(5): 808 - 815. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Craig, E. J. Bromet, S. Fennig, M. Tanenberg-Karant, J. Lavelle, and N. Galambos Is There an Association Between Duration of Untreated Psychosis and 24-Month Clinical Outcome in a First-Admission Series? Am J Psychiatry, January 1, 2000; 157(1): 60 - 66. [Abstract] [Full Text]
|
|
|
|
|
|
D. Robinson, M. G. Woerner, J. Ma. J. Alvir, R. Bilder, R. Goldman, S. Geisler, A. Koreen, B. Sheitman, M. Chakos, D. Mayerhoff, et al. Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder Arch Gen Psychiatry, March 1, 1999; 56(3): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The drug treatment of patients with schizophrenia DTB, November 1, 1995; 33(11): 81 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Johnstone, T.J. Crow, D.G.C. Owens, and C.D. Frith The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatment J Psychopharmacol, January 1, 1991; 5(4): 388 - 395. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |
